VIM and breast carcinoma: Vimentin also showed an increase in the invasive forms of ductal (P-value=0.0238, 95% CI -0.0816653 to -0.0057547) and lobular (P-value=0.1457, 95% CI -0.0060373 to 0.0406173) breast carcinomas.